Skip to content
Wenlo
Sign in
← Markets

Amgen Inc.

Omar Ishrak (Director) reports AMGN insider transactions

4AMGNFiled Nov 9, 2026, 7:46 PM ET· Period Nov 6, 2026

AI-generated summary

Director Omar Ishrak received 152.0351 shares as a grant of Common Stock on November 6, 2026. Following this transaction, the insider directly holds 7,681.9397 shares.

View original filing on SEC.gov (opens SEC EDGAR)

Key facts

Insider
Omar Ishrak · Director
DateTransactionSharesPriceValueHeld afterOwnership
Nov 6, 2026A · grantFootnotes F1, F2+152.0351$0.00$0.007,681.9397Direct
Footnotes
  1. F1 These shares include 504 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited to the reporting person's unvested Restricted Stock Units and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount.
  2. F2 The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Director Equity Incentive Program, as amended, under the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and vested immediately. Vested RSUs are paid in shares of the Company's common stock on a one-to-one basis. Vested RSUs may be deferred by the director, in which case payment will occur according to the elected deferral schedule.

More AMGN filings

Not investment advice. Summaries can contain errors; the SEC filing is the official record.